REYN vs CLX

For growth investors, Reynolds Consumer Products Inc.

(REYN) is the stronger pick with 0. 7% revenue growth year-over-year, versus 0. 2% for The Clorox Company (CLX). The Clorox Company (CLX) offers the better valuation at 14. 1x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Reynolds Consumer Products Inc. (REYN) a "Hold" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, The Clorox Company (CLX) is the cheapest at 14.

1x versus Reynolds Consumer Products Inc. at 15. 3x. On forward P/E, Reynolds Consumer Products Inc. is actually cheaper at 13. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Reynolds Consumer Products Inc.

(REYN) delivered a total return of -13. 5%, compared to -36. 6% for The Clorox Company (CLX). Over 10 years, the gap is even starker: CLX returned +2. 8% versus REYN's -4. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Clorox Company (CLX) is the lower-risk stock at 0.

42β versus Reynolds Consumer Products Inc. 's 0. 51β — meaning REYN is approximately 20% more volatile than CLX relative to the S&P 500. On balance sheet safety, Reynolds Consumer Products Inc. (REYN) carries a lower debt/equity ratio of 78% versus 6% for The Clorox Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Reynolds Consumer Products Inc.

(REYN) is pulling ahead at 0. 7% versus 0. 2% for The Clorox Company (CLX). On earnings-per-share growth, the picture is similar: The Clorox Company grew EPS 189. 8% year-over-year, compared to -14. 4% for Reynolds Consumer Products Inc.. Over a 3-year CAGR, CLX leads at -0. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Clorox Company (CLX) is the more profitable company, earning 11.

4% net margin versus 8. 1% for Reynolds Consumer Products Inc. — meaning it keeps 11. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLX leads at 16. 6% versus 13. 2% for REYN. At the gross margin level — before operating expenses — CLX leads at 45. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Reynolds Consumer Products Inc.

(REYN) trades at 13. 8x forward P/E versus 15. 7x for The Clorox Company — 1. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLX: 14. 5% to $105. 50.

All stocks in this comparison pay dividends.

The Clorox Company (CLX) offers the highest yield at 5. 3%, versus 4. 2% for Reynolds Consumer Products Inc. (REYN).

For long-horizon retirement investors, The Clorox Company (CLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

42), 5. 3% yield). Both have compounded well over 10 years (CLX: +2. 8%, REYN: -4. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (REYN (Consumer Cyclical) and CLX (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.